Ingalls & Snyder LLC’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
+10,000
| New | +$115K | ﹤0.01% | 430 |
|
|
2022
Q3 | – | Sell |
-10,000
| Closed | -$198K | – | 414 |
|
|
2022
Q2 | $198K | Hold |
10,000
| – | – | 0.01% | 388 |
|
|
2022
Q1 | $316K | Buy |
+10,000
| New | +$316K | 0.01% | 343 |
|
|
2018
Q4 | – | Sell |
-1,783
| Closed | -$207K | – | 402 |
|
|
2018
Q3 | $207K | Hold |
1,783
| – | – | 0.01% | 402 |
|
|
2018
Q2 | $225K | Buy |
+1,783
| New | +$225K | 0.01% | 352 |
|
|
2017
Q2 | – | Sell |
-3,248
| Closed | -$375K | – | 383 |
|
|
2017
Q1 | $375K | Sell |
3,248
-26
| -0.8% | -$3K | 0.02% | 279 |
|
|
2016
Q4 | $393K | Sell |
3,274
-34
| -1% | -$4.08K | 0.02% | 270 |
|
|
2016
Q3 | $372K | Hold |
3,308
| – | – | 0.02% | 272 |
|
|
2016
Q2 | $410K | Buy |
3,308
+187
| +6% | +$23.2K | 0.02% | 269 |
|
|
2016
Q1 | $350K | Hold |
3,121
| – | – | 0.02% | 262 |
|
|
2015
Q4 | $339K | Hold |
3,121
| – | – | 0.02% | 272 |
|
|
2015
Q3 | $311K | Hold |
3,121
| – | – | 0.02% | 279 |
|
|
2015
Q2 | $355K | Sell |
3,121
-187
| -6% | -$21.3K | 0.02% | 269 |
|
|
2015
Q1 | $345K | Hold |
3,308
| – | – | 0.02% | 272 |
|
|
2014
Q4 | $398K | Hold |
3,308
| – | – | 0.02% | 262 |
|
|
2014
Q3 | $484K | Hold |
3,308
| – | – | 0.03% | 242 |
|
|
2014
Q2 | $552K | Sell |
3,308
-7
| -0.2% | -$1.17K | 0.03% | 234 |
|
|
2014
Q1 | $657K | Sell |
3,315
-240
| -7% | -$47.6K | 0.04% | 213 |
|
|
2013
Q4 | $678K | Sell |
3,555
-6
| -0.2% | -$1.14K | 0.04% | 207 |
|
|
2013
Q3 | $602K | Sell |
3,561
-140
| -4% | -$23.7K | 0.04% | 216 |
|
|
2013
Q2 | $561K | Buy |
+3,701
| New | +$561K | 0.04% | 215 |
|